Publication | Closed Access

Serum thymidine kinase 1 correlates to clinical stages and clinical reactions and monitors the outcome of therapy of 1,247 cancer patients in routine clinical settings

MedicinePathologyImmune Checkpoint InhibitorClinical ReactionsClinical StagesCancer PatientsCancer TreatmentThyroid HormoneOncologyRadiation OncologyTumor MicroenvironmentCancer Research